anti-Chemokine (C-C Motif) Receptor 9 (CCR9) Antikörper

CCR9 encodes a beta chemokine receptor, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Zusätzlich bieten wir Ihnen Chemokine (C-C Motif) Receptor 9 Proteine (4) und Chemokine (C-C Motif) Receptor 9 Kits (1) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
CCR9 59289 O08707
CCR9 1238 O00590
CCR9 282832  
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Chemokine (C-C Motif) Receptor 9 Antikörper auf antikoerper-online.de

Showing 10 out of 246 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Maus Unkonjugiert CyTOF, FACS, ICC, IHC CCR9 in MOLT-4 Human Cell Line. CCR9 was detected in immersion fixed MOLT-4 human acute lymphoblastic leukemia cell line using Mouse Anti-Human CCR9 Monoclonal Antibody. Specific staining was localized to plasma membranes. CCR9 in MOLT-4 Human Cell Line. CCR9 was detected in immersion fixed MOLT-4 human acute lymphoblastic leukemia cell line using Mouse Anti-Human CCR9 Monoclonal Antibody  at 25 ug/mL for 3 hours at room temperature. Cells were stained using the NorthernLightsル 557-conjugated Anti-Mouse IgG Secondary Antibody (red 100 μg Anmelden zum Anzeigen 3 bis 4 Tage
254,00 €
Details
Maus Ratte Unkonjugiert ICC, IHC (fro), FACS, IF 1 mL Anmelden zum Anzeigen 3 bis 4 Tage
437,80 €
Details
Human Kaninchen Unkonjugiert WB CCR9 Antibody (C-term) (ABIN657775) western blot analysis in MDA-MB435 cell line lysates (35 µg/lane). This demonstrates the CCR9 antibody detected the CCR9 protein (arrow). 400 μL Anmelden zum Anzeigen 14 bis 16 Tage
335,24 €
Details
Maus Ratte Fluorescein FACS Detection of CCR9 in Mouse Thymocytes by Flow Cytometry. Mouse thymocytes were stained with Rat Anti-Mouse CCR9 Fluorescein-conjugated Monoclonal Antibody. Detection of CCR9 in Mouse Thymocytes by Flow Cytometry. Mouse thymocytes were stained with Rat Anti-Mouse CCR9 Fluorescein-conjugated Monoclonal Antibody. 25 Tests Anmelden zum Anzeigen 3 bis 4 Tage
107,00 €
Details
Maus Ratte PE FACS Detection of CCR9 in Mouse Thymocytes by Flow Cytometry. Mouse thymocytes were stained with Rat Anti-Mouse CCR9 PE-conjugated Monoclonal Antibody. Detection of CCR9 in Mouse Thymocytes by Flow Cytometry. Mouse thymocytes were stained with Rat Anti-Mouse CCR9 PE-conjugated Monoclonal Antibody. 25 Tests Anmelden zum Anzeigen 3 bis 4 Tage
107,00 €
Details
Maus Ratte Allophycocyanin FACS Detection of CCR9 in Rat Splenocytes by Flow Cytometry. Rat splenocytes were stained with Rat Anti-Mouse/Rat CCR9 APC-conjugated Monoclonal Antibody. Detection of CCR9 in Mouse Thymocytes by Flow Cytometry. Mouse thymocytes were stained with Rat Anti-Mouse/Rat CCR9 APC-conjugated Monoclonal Antibody. 25 Tests Anmelden zum Anzeigen 3 bis 4 Tage
116,00 €
Details
Human Ziege Unkonjugiert FACS, IHC (p), IHC, ELISA, WB Immunohistochemistry on mouse spleen Immunohistochemistry-Paraffin: CCR9 Antibody [ABIN152131] - Analysis using the Biotin conjugate of ABIN152131. Staining of mouse spleen. 0.1 mg Anmelden zum Anzeigen 2 bis 4 Tage
291,00 €
Details
Human Maus Fluorescein FACS Detection of CCR9 in MOLT-4 Human Cell Line by Flow Cytometry. MOLT-4 human acute lymphoblastic leukemia cell line was stained with Mouse Anti-Human CCR9 Fluorescein-conjugated Monoclonal Antibody. Detection of CCR9 in MOLT-4 Human Cell Line by Flow Cytometry. MOLT-4 human acute lymphoblastic leukemia cell line was stained with Mouse Anti-Human CCR9 Fluorescein-conjugated Monoclonal Antibody. 25 Tests Anmelden zum Anzeigen 3 bis 4 Tage
125,00 €
Details
Human Maus PE FACS Detection of CCR9 in MOLT-4 Human Cell Line by Flow Cytometry. MOLT-4 human acute lymphoblastic leukemia cell line was stained with Mouse Anti-Human CCR9 PE-conjugated Monoclonal Antibody. Detection of CCR9 in MOLT-4 Human Cell Line by Flow Cytometry. MOLT-4 human acute lymphoblastic leukemia cell line was stained with Mouse Anti-Human CCR9 PE-conjugated Monoclonal Antibody. 25 Tests Anmelden zum Anzeigen 3 bis 4 Tage
125,00 €
Details
Human Maus Allophycocyanin FACS Detection of CCR9 in MOLT-4 Human Cell Line by Flow Cytometry. MOLT-4 human acute lymphoblastic leukemia cell line was stained with Mouse Anti-Human CCR9 APC-conjugated Monoclonal Antibody. Detection of CCR9 in MOLT-4 Human Cell Line by Flow Cytometry. MOLT-4 human acute lymphoblastic leukemia cell line was stained with Mouse Anti-Human CCR9 APC-conjugated Monoclonal Antibody. 25 Tests Anmelden zum Anzeigen 3 bis 4 Tage
134,00 €
Details

CCR9 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Mouse (Murine) , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Human , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , , , ,
, ,
,
, , , , , , , , , , , , , , , , ,

Am meisten referenzierte anti-Chemokine (C-C Motif) Receptor 9 Antikörper

  1. Human Monoclonal CCR9 Primary Antibody für FACS - ABIN4895572 : Hosomi, Oshitani, Kamata, Sogawa, Okazaki, Tanigawa, Yamagami, Watanabe, Tominaga, Watanabe, Fujiwara, Maeda, Hirakawa, Arakawa: Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. in Clinical and experimental immunology 2011 (PubMed)
    Show all 7 Pubmed References

  2. Human Monoclonal CCR9 Primary Antibody für FACS - ABIN4895571 : Sundström, Ahlmanner, Akéus, Sundquist, Alsén, Yrlid, Börjesson, Sjöling, Gustavsson, Wong, Quiding-Järbrink: Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ. in Journal of immunology (Baltimore, Md. : 1950) 2015 (PubMed)
    Show all 7 Pubmed References

  3. Human Monoclonal CCR9 Primary Antibody für CyTOF, FACS - ABIN4899104 : Minang, Trivett, Bolton, Trubey, Estes, Li, Smedley, Pung, Rosati, Jalah, Pavlakis, Felber, Piatak, Roederer, Lifson, Ott, Ohlen et al.: Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during ... in Journal of immunology (Baltimore, Md. : 1950) 2009 (PubMed)
    Show all 6 Pubmed References

  4. Mouse (Murine) Monoclonal CCR9 Primary Antibody für CyTOF, FACS - ABIN4899103 : Ueha, Murai, Yoneyama, Kitabatake, Imai, Shimaoka, Yonehara, Ishikawa, Matsushima: Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. in Journal of leukocyte biology 2006 (PubMed)
    Show all 6 Pubmed References

  5. Human Monoclonal CCR9 Primary Antibody für FACS - ABIN4895569 : Johnson-Holiday, Singh, Johnson, Singh, Stockard, Grizzle, Lillard: CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. in International journal of oncology 2011 (PubMed)
    Show all 3 Pubmed References

  6. Human Monoclonal CCR9 Primary Antibody für FACS - ABIN4895570 : Sen, Chunsong, Baojun, Linjie, Qun, San, Qiuping, Junyan, Zhang, Jinquan: Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells. in Immunology 2004 (PubMed)
    Show all 3 Pubmed References

  7. Mouse (Murine) Monoclonal CCR9 Primary Antibody für FACS - ABIN4895579 : Takeuchi, Yokota, Ohoka, Kagechika, Kato, Song, Iwata: Efficient induction of CCR9 on T cells requires coactivation of retinoic acid receptors and retinoid X receptors (RXRs): exaggerated T Cell homing to the intestine by RXR activation with organotins. in Journal of immunology (Baltimore, Md. : 1950) 2010 (PubMed)
    Show all 3 Pubmed References

  8. Mouse (Murine) Monoclonal CCR9 Primary Antibody für FACS - ABIN4895580 : Muller, Sonkoly, Eulert, Gerber, Kubitza, Schirlau, Franken-Kunkel, Poremba, Snyderman, Klotz, Ruzicka, Bier, Zlotnik, Whiteside, Homey, Hoffmann: Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. in International journal of cancer 2006 (PubMed)
    Show all 3 Pubmed References

  9. Mouse (Murine) Monoclonal CCR9 Primary Antibody für FACS - ABIN4895573 : Uematsu, Fujimoto, Jang, Yang, Jung, Nishiyama, Sato, Tsujimura, Yamamoto, Yokota, Kiyono, Miyasaka, Ishii, Akira: Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. in Nature immunology 2008 (PubMed)
    Show all 2 Pubmed References

  10. Mouse (Murine) Monoclonal CCR9 Primary Antibody für FACS - ABIN2472924 : De Jongh, Warner, Colvin, Catterall: Characterization of the two size forms of the alpha 1 subunit of skeletal muscle L-type calcium channels. in Proceedings of the National Academy of Sciences of the United States of America 1992 (PubMed)
    Show all 3 Pubmed References

Weitere Antikörper gegen Chemokine (C-C Motif) Receptor 9 Interaktionspartner

Mouse (Murine) Chemokine (C-C Motif) Receptor 9 (CCR9) Interaktionspartner

  1. study found that the inflammatory chemokine (zeige CCL1 Antikörper) CCL5 (zeige CCL5 Antikörper) is mostly retained (75%) during the resolution of zymosan A peritonitis in mice; CCL5 (zeige CCL5 Antikörper) exerts a novel proresolving role on macrophages when acting in concert with apoptotic PMN (zeige TBCE Antikörper)-expressed D6.

  2. CCR9 and CCL25 (zeige CCL25 Antikörper) expressions are induced in the early stages of airway inflammation and they have an important role modulating eosinophils and lymphocytes recruitment at the first stages of inflammatory process

  3. CCR9 and Integrin-beta7 expression has a differential effect on graft fate during acute graft-versus-host disease (GVHD) of the liver depending on the GVHD target tissue.

  4. data indicate that in addition to acting as a gut (zeige GUSB Antikörper)-homing molecule, CCR9 signaling shapes immune responses by inhibiting Treg cell development

  5. Data suggest that blocking CC chemokine receptor 9 (CCR9) may represent a novel safe therapy for rheumatoid arthritis (RA).

  6. activation of Notch1 (zeige NOTCH1 Antikörper) has a dominant-negative effect on Ccr9 transcription and that Notch1 (zeige NOTCH1 Antikörper) and E proteins control the dynamic expression of Ccr9 during T cell development.

  7. ACKR2 can regulate fetal (zeige CCL1 Antikörper) growth, placental structure, and neonatal mortality in mice.

  8. Further examination revealed that proximity of pro-lymphangiogenic macrophages to developing lymphatic vessel surfaces is increased in ACKR2-deficient mice and reduced in CCR2-deficient mice.

  9. some cells, including plasmacytoid dendritic cells, can express both CCR2 (zeige CCR2 Antikörper) and ACKR2; that Ly6C(high) monocytes have particularly strong CCL2 (zeige CCL2 Antikörper)-scavenging potential in vitro and in vivo; and that CCR2 (zeige CCR2 Antikörper) is a much more effective CCL2 (zeige CCL2 Antikörper) scavenger than ACKR2.

  10. CCR9/CCL25 (zeige CCL25 Antikörper) is involved in acute skin transplantation rejection and anti-CCL25 (zeige CCL25 Antikörper) strategies might be useful in preventing acute rejection.

Human Chemokine (C-C Motif) Receptor 9 (CCR9) Interaktionspartner

  1. this study showed that CCR7 (zeige CCR7 Antikörper) are overexpressed in CD4 (zeige CD4 Antikörper)(-) CD8 (zeige CD8A Antikörper)(-) thymocytes of myasthenia gravis patients.

  2. Results indicated that the expression levels of CCR9 in lesional skin may be a useful biologic marker of the clinical efficacy of infliximab therapy in psoriasis patients.

  3. Xray crystal structure of the CCR9 receptor in complex with vercirnon at 2.8 A resolution

  4. that CCL25 (zeige CCL25 Antikörper)/CCR9 signal may provide cancer cells with chemotactic abilities through influencing several epithelial-mesenchymal transitionmarkers

  5. Studies indicate important roles played by chemokine ligand 25 (CCL25 (zeige CCL25 Antikörper))/chemokine receptor 9 (CCR9) in tumorigenesis, tumor chemoresistance and metastasis.

  6. CCR9 and Integrin-beta7 expression has a differential effect on graft fate during acute graft-versus-host disease (GVHD) of the liver depending on the GVHD target tissue.

  7. CCR9 mRNA and protein levels were significantly increased in the nasopharyngeal carcinoma group compared with the control group.

  8. CCR9-CCL25 (zeige CCL25 Antikörper) interaction promoted proliferation and suppressed apoptosis of non-small cell lung cancer cells by activating the PI3K (zeige PIK3CA Antikörper)/Akt (zeige AKT1 Antikörper) pathway.

  9. CCR9 could be beneficial in predicting lymph node metastasis, and it might act as a novel prognostic biomarker for lung adenocarcinoma.

  10. We also show that primary tumors can be modeled in immunocompetent mice by microinjecting CCR9-expressing cancer cell lines into early-stage mouse blastocysts, which induces central immune tolerance

Chemokine (C-C Motif) Receptor 9 (CCR9) Antigen-Profil

Protein Überblick

The protein encoded by this gene is a member of the beta chemokine receptor family. It is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptors are key regulators of the thymocytes migration and maturation in normal and inflammation conditions. The specific ligand of this receptor is CCL25. It has been found that this gene is differentially expressed by T lymphocytes of small intestine and colon, suggested a role in the thymocytes recruitment and development that may permit functional specialization of immune responses in different segment of the gastrointestinal tract. This gene is mapped to the chemokine receptor gene cluster region. Two alternatively spliced transcript variants have been described. Multiple transcript variants encoding different isoforms have been found for this gene.

Genbezeichner und Symbole assoziert mit CCR9

  • chemokine (C-C motif) receptor 9 (CCR9) Antikörper
  • atypical chemokine receptor 2 (Ackr2) Antikörper
  • atypical chemokine receptor 2 (ACKR2) Antikörper
  • chemokine (C-C motif) receptor 9 (Ccr9) Antikörper
  • A130091K22Rik Antikörper
  • AI464239 Antikörper
  • CC-CKR-9 Antikörper
  • CCBP2 Antikörper
  • CCR9 Antikörper
  • CCR10 Antikörper
  • CDw199 Antikörper
  • CMKBR9 Antikörper
  • Cmkbr10 Antikörper
  • D6 Antikörper
  • GPR-9-6 Antikörper
  • GPR28 Antikörper
  • hD6 Antikörper

Bezeichner auf Proteinebene für CCR9

C-C chemokine receptor D6 , D6 beta-chemokine receptor , chemokine binding protein 2 , chemokine-binding protein 2 , chemokine-binding protein D6 , CC-chemokine-binding receptor JAB61 , chemokine (C-C motif) receptor 9 , chemokine (C-C) receptor 9 , chemokine receptor CCR-10 , chemokine receptor CCR-9 , chemokine receptor D6 , C-C chemokine receptor type 9 , G protein-coupled receptor 28 , C-C CKR-9 , CC-CKR-9 , CCR-9 , chemokine C-C receptor 10 , chemokine C-C motif receptor 9

GENE ID SPEZIES
100065535 Equus caballus
59289 Mus musculus
1238 Homo sapiens
10803 Homo sapiens
12769 Mus musculus
282832 Rattus norvegicus
484793 Canis lupus familiaris
530951 Bos taurus
678667 Ovis aries
Ausgewählte Anbieter für anti-Chemokine (C-C Motif) Receptor 9 (CCR9) Antikörper
Haben Sie etwas anderes gesucht?